Back to FDMT
GOLDMAN SACHS GROUP INC → FDMT
GOLDMAN SACHS GROUP INC FDMT Position History
4D Molecular Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$5.6M
Q2 2026
Peak value
$51M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $13.9M |
| Q2 2025 | $1.6M |
| Q3 2025 | $32.2M |
| Q3 2025 | $3.7M |
| Q4 2025 | $3.2M |
| Q4 2025 | $157K |
| Q4 2025 | $29M |
| Q4 2025 | $29M |
| Q4 2025 | $157K |
| Q4 2025 | $3.2M |
| Q1 2026 | $35.2M |
| Q1 2026 | $3.9M |
| Q2 2026 | $51M |
| Q2 2026 | $5.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $5.6M | 421.3K | — | — |
| Q2 2026 | $51M | 3.84M | — | — |
| Q1 2026 | $3.9M | 421.3K | — | — |
| Q1 2026 | $35.2M | 3.78M | — | — |
| Q4 2025 | $3.2M | 421.3K | — | — |
| Q4 2025 | $157K | 20.9K | — | — |
| Q4 2025 | $29M | 3.86M | — | — |
| Q4 2025 | $29M | 3.86M | — | — |
| Q4 2025 | $157K | 20.9K | — | — |
| Q4 2025 | $3.2M | 421.3K | — | — |
| Q3 2025 | $3.7M | 421.2K | — | — |
| Q3 2025 | $32.2M | 3.71M | — | — |
| Q2 2025 | $1.6M | 420.0K | — | — |
| Q2 2025 | $13.9M | 3.74M | — | — |